Endocrine

, 40:151

Surgical treatment of type 2 diabetes: the surgeon perspective

  • Alpana P. Shukla
  • Soo Min Ahn
  • Rajesh T. Patel
  • Matthew W. Rosenbaum
  • Francesco Rubino
Review

DOI: 10.1007/s12020-011-9508-8

Cite this article as:
Shukla, A.P., Ahn, S.M., Patel, R.T. et al. Endocrine (2011) 40: 151. doi:10.1007/s12020-011-9508-8

Abstract

Type 2 diabetes mellitus (T2DM) is a major health priority globally, having achieved pandemic status in the twenty-first century. Several gastrointestinal procedures that were primarily designed to treat morbid obesity result in dramatic remission of diabetes. Studies in experimental rodent models and humans have shown that the glycemic benefits of surgery are at least in part weight-independent and extend to non-morbidly obese subjects with T2DM. Bariatric procedures differ in their ability to ameliorate type 2 diabetes, with intestinal bypass procedures being more effective than purely restrictive procedures. Several studies have demonstrated that the benefits of bariatric surgery extend beyond amelioration of hyperglycemia and include improvement in other cardiovascular risk factors such as dyslipidemia and hypertension. The safety and cost-effectiveness of bariatric surgery are also well established by several studies. In this paper, the authors present the surgeon perspective on the management of type 2 diabetes focusing on the efficacy, safety and cost-effectiveness of metabolic surgery. The available evidence warrants the inclusion of metabolic surgery in the treatment algorithm of type 2 diabetes.

Keywords

Type 2 diabetes mellitus (T2DM) Metabolic surgery Efficacy Safety Cost-effectiveness 

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Alpana P. Shukla
    • 1
  • Soo Min Ahn
    • 1
  • Rajesh T. Patel
    • 1
  • Matthew W. Rosenbaum
    • 1
  • Francesco Rubino
    • 1
  1. 1.Section of GI Metabolic SurgeryNew York Presbyterian Hospital and Weill Cornell Medical CollegeNew YorkUSA